Anthony Alberg, PhD
- Associate Professor - Adjunct
- Epidemiology (Affiliated)
Center & Institute Affiliations
PhD, Johns Hopkins University
MPH, Yale University
My primary appointment is Associate Director for Cancer Prevention and Control at the Hollings Cancer Center, Blatt Ness Chair and Associate Professor of Epidemiology at the Medical University of South Carolina in Charleston, South Carolina.
A current NCI-funded R01, based in the CLUE II study, is assessing the potential role of variation in DNA repair pathways in explaining the increased risk of noncutaneous malignancies observed in persons with a history of nonmelanoma skin cancer.
Other major interests center around the contribution of active and passive cigarette smoking to cancer etiology and tobacco control. This has included research in areas such as secondhand smoke and cancer, the use of nicotine replacement therapies in populations, and the epidemiology of lung cancer.
- cancer epidemiology cancer prevention cancer control skin cancer tobacco health effects tobacco prevention and control cigarette smoking lung cancer breast cancer head and neck cancer passive smoking secondhand smoke screening early detection
SKIN CANCER AS A RISK FOR OTHER MALIGNANCIES:
Chen J, Ruczinski I, Jorgensen TJ, Yenokyan G, Yao Y, Alani R, Liégeois NJ, Hoffman SC, Hoffman-Bolton J, Strickland PT, Helzlsouer KJ, Alberg AJ. Nonmelanoma skin cancer and risk for subsequent malignancy. Journal of the National Cancer Institute 2008; 100: 1215-1222.
Alberg AJ, Chen J, Ruczinski I, Jorgensen TJ, Alani R, Liegeois NJ. Response Re: Nonmelanoma and risk of subsequent malignancy. J Natl Cancer Inst 2009; 101: 210-211. (Letter to the Editor)
Brewster AM, Alberg AJ, Strickland PT, Hoffman SC, Helzlsouer KJ. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarker Prev 2004; 13: 1271-1275.